Clinical Trials Directory

Trials / Completed

CompletedNCT04482491

Histological Prediction and Choice of the Resection Strategy in Front of a Colorectal Lesion > 2 cm: Prospective Comparison of Endoscopic Characterization, Non-targeted and Targeted Biopsies

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Hôpital Edouard Herriot · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Colorectal cancer has become a public health priority considering its increased prevalence and high mortality rate when diagnosed late. As a consequence, many countries have promoted and uptaken of colorectal cancer screening programs leading to an increasing detection of advanced but also superficial lesions ESGE (European Society of Gastrointestinal Endoscopy) guidelines states that the majority of those colonic and rectal superficial lesions can be removed in a curative way by standard polypectomy and/or by EMR (Endoscopic Mucosal Resection) and that ESD (Endoscopic Submucosal Dissection) can be considered for removal of colonic and rectal lesions with high suspicion of limited submucosal invasion. Histologically, a resection is curative for the patient when the adenocarcinoma is well-differentiated (G1/G2), with a depth of invasion ≤ sm1 (≤ 1 mm submucosal invasion), with no lymphovascular invasion nor budding and with lateral and deep margins free of cancer

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic Submucosal DissectionEndoscopic Submucosal Dissection

Timeline

Start date
2019-01-01
Primary completion
2019-01-01
Completion
2020-01-01
First posted
2020-07-22
Last updated
2020-07-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04482491. Inclusion in this directory is not an endorsement.